These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 29929092)

  • 21. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
    J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
    Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
    Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
    Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
    J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.
    Davis EJ; Chugh R; Zhao L; Lucas DR; Biermann JS; Zalupski MM; Feng M; Wong SL; Jacobson J; Zyczynski L; Reinke D; Metko G; Baker LH; Schuetze SM
    Eur J Cancer; 2015 Sep; 51(13):1794-802. PubMed ID: 26066736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
    Spunt SL; Million L; Chi YY; Anderson J; Tian J; Hibbitts E; Coffin C; McCarville MB; Randall RL; Parham DM; Black JO; Kao SC; Hayes-Jordan A; Wolden S; Laurie F; Speights R; Kawashima E; Skapek SX; Meyer W; Pappo AS; Hawkins DS
    Lancet Oncol; 2020 Jan; 21(1):145-161. PubMed ID: 31786124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
    Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.
    Alvegård TA; Sigurdsson H; Mouridsen H; Solheim O; Unsgaard B; Ringborg U; Dahl O; Nordentoft AM; Blomqvist C; Rydholm A
    J Clin Oncol; 1989 Oct; 7(10):1504-13. PubMed ID: 2674336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
    Issels RD; Abdel-Rahman S; Wendtner C; Falk MH; Kurze V; Sauer H; Aydemir U; Hiddemann W
    Eur J Cancer; 2001 Sep; 37(13):1599-608. PubMed ID: 11527684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
    Schuetze SM; Patel S
    Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
    Wang B; Yu X; Xu S; Xu M
    Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
    Khanfir K; Alzieu L; Terrier P; Le Péchoux C; Bonvalot S; Vanel D; Le Cesne A
    Eur J Cancer; 2003 Sep; 39(13):1872-80. PubMed ID: 12932665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
    Filleron T; Le Guellec S; Chevreau C; Cabarrou B; Lesluyes T; Lodin S; Massoubre A; Mounier M; Poublanc M; Chibon F; Valentin T
    BMC Cancer; 2020 Jul; 20(1):716. PubMed ID: 32736540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
    Wendtner C; Abdel-Rahman S; Baumert J; Falk MH; Krych M; Santl M; Hiddemann W; Issels RD
    Eur J Cancer; 2001 Sep; 37(13):1609-16. PubMed ID: 11527685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
    Coindre JM; Terrier P; Bui NB; Bonichon F; Collin F; Le Doussal V; Mandard AM; Vilain MO; Jacquemier J; Duplay H; Sastre X; Barlier C; Henry-Amar M; Macé-Lesech J; Contesso G
    J Clin Oncol; 1996 Mar; 14(3):869-77. PubMed ID: 8622035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience.
    Fernberg JO; Hall KS
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):77-86. PubMed ID: 15188669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
    Goy BW; Syed S; Padmanabhan A; Burchette RJ; Helmstedter CS
    Radiother Oncol; 2021 Dec; 165():174-178. PubMed ID: 34758339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
    Gustafson P
    Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy.
    Brandts CH; Schulz C; Willich N; Steffen B; Hardes J; Gosheger G; Winkelmann W; Serve H; Heinecke A; Berdel WE; Thomas M
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):613-20. PubMed ID: 21947168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.